收藏切换
Investigation and Analysis of Imatinib Adherence and Quality of Life of Patients with Gastrointestinal Stromal Tumor
收藏切换
PDF
Li LIU1, 2, Hefen CHEN1, 2, Ziying FAN1, 2, Xiao HUANG1, 2, Linhua CHEN1, 2, Yushi ZHAO1, 2, Zhiliang CHEN3, Peng ZHANG3, Hong ZHOU1, 2, *
Chinese Pharmaceutical Journal | 2025, 60(7) : 755 - 762
Less
收藏切换
Chinese Pharmaceutical Journal | 2025, 60(7): 755-762
Investigation and Analysis of Imatinib Adherence and Quality of Life of Patients with Gastrointestinal Stromal Tumor
Full
Li LIU1, 2, Hefen CHEN1, 2, Ziying FAN1, 2, Xiao HUANG1, 2, Linhua CHEN1, 2, Yushi ZHAO1, 2, Zhiliang CHEN3, Peng ZHANG3, Hong ZHOU1, 2, *
Affiliations
  • 1 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • 2 Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China
  • 3 Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Published: 2025-04-08 doi: 10.11669/cpj.2025.07.011
Outline
收藏切换

OBJECTIVE To investigate the imatinib mesylate (IM) adherence and health-related quality of life (HRQoL) of gastrointestinal stromal tumor (GIST) patients, and further identify the influencing factors. METHODS Patients who visited the GIST specialty clinic between April 2022 and April 2024 were enrolled. All eligible patients completed a composite questionnaire, including the basic situation, adherence, HRQoL, and adverse events. Then the influencing factors of adherence and HRQoL were analyzed. RESULTS A total of 227 GIST patients were enrolled, and the IM adherence rate was 48.5%. The main non-adherence factors were living in rural area for extended periods, concomitant disease, without therapeutic drug monitoring (TDM), impaired cognitive function, pain, dyspnea, insomnia, fatigue, and gastrointestinal adverse effects. Multivariate logistic regression analysis showed that TDM and no pain were promoters of adherence. The risk factors for global health status were female, unemployment, monthly income less than 3000 yuan, concomitant medications and anemia, and such patients had lower functioning score and higher symptom burden. Multivariate logistic regression analysis showed that gender was a predictor of global health status. CONCLUSION Patients with GIST often exhibit low adherence to IM, and various factors can impact both adherence and HRQoL. In the future, medical workers can play a crucial role in providing medication education and guidance, adverse events management, TDM, and interventions for patients with specific risk factors to enhance IM adherence and overall well-being of patients with GIST.

gastrointestinal stromal tumor  /  imatinib  /  adherence  /  health-related quality of life
Li LIU, Hefen CHEN, Ziying FAN, Xiao HUANG, Linhua CHEN, Yushi ZHAO, Zhiliang CHEN, Peng ZHANG, Hong ZHOU. Investigation and Analysis of Imatinib Adherence and Quality of Life of Patients with Gastrointestinal Stromal Tumor[J]. Chinese Pharmaceutical Journal, 2025 , 60 (7) : 755 -762 . DOI: 10.11669/cpj.2025.07.011
Year 2025 volume 60 Issue 7
PDF
142
46
Cite this Article
BibTeX
Article Info
doi: 10.11669/cpj.2025.07.011
  • Receive Date:2024-10-31
  • Online Date:2025-11-11
  • Published:2025-04-08
Article Data
Affiliations
History
  • Received:2024-10-31
Funding
Affiliations
    1 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
    2 Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China
    3 Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2025.07.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT